SCHEDULE 13G/A: BlackRock Amends Exact Sciences Stake, Reports 4.3% Passive Ownership

BlackRock, Inc. has filed an Amendment No. 3 to its Schedule 13G, disclosing a 4.3% beneficial ownership stake in Exact Sciences Corp. common stock as of June 30, 2025.

Summary

• BlackRock, Inc. filed an Amendment No. 3 to its Schedule 13G regarding its ownership in EXACT SCIENCES CORP.
• As of June 30, 2025, BlackRock, Inc. beneficially owns 8,070,493 shares of EXACT SCIENCES CORP common stock.
• This beneficial ownership represents 4.3% of the total outstanding common stock of EXACT SCIENCES CORP.
• BlackRock holds sole voting power over 7,502,047 shares and sole dispositive power over 8,070,493 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The document is a routine disclosure of a passive stake by a major institutional investor. It confirms BlackRock's continued, albeit passive, investment in Exact Sciences, which can be seen as a minor positive signal of confidence, but it contains no new operational or financial news.

Positives

• BlackRock, a major institutional investor, maintains a significant passive stake in Exact Sciences Corp., indicating continued investment interest.
• The filing confirms BlackRock's passive investment intent, stating the shares are held in the ordinary course of business and not for control purposes.

Negatives

• The document does not contain information that would be considered negative for Exact Sciences Corp.

Risks

• The document is an ownership disclosure and does not explicitly detail risks related to Exact Sciences Corp.'s operations or financial performance.

Future Outlook

The document is a disclosure of current beneficial ownership and does not provide forward-looking statements or guidance regarding the issuer's future performance or BlackRock's future investment intentions beyond the passive nature of the current holding.

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

This filing is a routine disclosure by a large asset manager, BlackRock, regarding its passive investment in Exact Sciences Corp. It reflects BlackRock's ongoing portfolio management activities and does not indicate any specific industry trends or competitive shifts, beyond the continued presence of a major institutional investor in the healthcare diagnostics sector.

Comparison to Industry Standards

• This document is a standard Schedule 13G filing, which is a regulatory requirement for passive investors holding less than 5% of a company's outstanding shares.
• BlackRock's holding of 4.3% in Exact Sciences Corp. is consistent with typical institutional portfolio allocations and does not suggest any deviation from standard investment practices for large asset managers.
• No specific comparable companies or projects are mentioned within the document to allow for a detailed comparative assessment of results.

Stakeholder Impact

• Shareholders: Provides transparency on a significant institutional holding, confirming a major investor's passive stake.
• Employees, Customers, Suppliers, Creditors: No direct impact indicated by this ownership disclosure.

Next Steps

• The document does not outline any specific future actions or milestones for Exact Sciences Corp. or BlackRock beyond the ongoing regulatory compliance for beneficial ownership.

Key Dates

Keywords

Exact Sciences Corp, BlackRock, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Passive Investment